Inside The COVID-19 Bill: Breaking Down The Pharma Policy Provisions
What's in – and what fell out of – the massive US stimulus package.
You may also be interested in...
Amendment to require one-firth of the money be devoted to therapeutic review was defeated by the House Energy and Commerce Committee.
The $500m in additional funds would support pandemic-related activities, potentially for additional staff or technology upgrades.
Proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.